AtriCure, Inc.

ATRC Healthcare Medical Instruments & Supplies

AtriCure, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $534.5 million, up 14.9% from fiscal 2024.

Revenue
+15.0%
EPS
+1,583.9%
Free cash flow
−0.73%
Total debt
−17.3%

Quarter to September 2026, against a year earlier

60.70 4.83 −7.37%
Market cap
$3.1B
P/E
199×
Fwd P/E
573×
Dividend yield
—
F-score
7/9
Altman Z
7.31
Beneish M
−2.91
Dividend safety
n/a

AtriCure, Inc. (ATRC) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, AtriCure, Inc. (ATRC) trades at a P/E ratio of 199×. Over the past ten years it has ranged from 0.0× (June 2026) to 281× (September 2026); the current reading is higher than 99% of that period. That is above the Medical Instruments & Supplies industry median of 30.3× and above the Healthcare sector median of 25.2×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 0.0× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 62.6× —
FY2020 0.0× —
FY2019 0.0× —
FY2018 0.0× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly newest first

Period P/E ratio Change
Sep 2026 184× 42.50%
Jun 2026 129× —
Mar 2026 0.0× —
Dec 2025 0.0× —
43 more quarters

Against its own ten years

Low 0.0× High 281×
Ten-year median 0.0×
Current reading's percentile 99

P/E ratio against peers

Company P/E ratio
PLSE Pulse Biosciences, Inc compare n/m
MMED MiniMed Group, Inc. compare n/m
XRAY DENTSPLY SIRONA Inc. compare n/m
NVST Envista Holdings Corporation compare 6.4×
STVN Stevanato Group S.p.A. compare 22.4×
MMSI Merit Medical Systems, Inc. compare 33.2×
ICUI ICU Medical, Inc. compare 69.3×
ATRC AtriCure, Inc. 199×
WRBY Warby Parker Inc. compare 434×
Medical Instruments & Supplies industry median 30.3×
Healthcare sector median 25.2×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on ATRC